ACT-HIB polvere E solvente PER soluzione iniettabile IN siringa preriempita 0,5 ML
( DrugBank: - / KEGG DRUG: - )
2 diseases
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
61 | Autoimmune hemolytic anemia | 1 |
ID | Disease name (Link within this page) | Number of trials |
---|---|---|
62 | Paroxysmal nocturnal hemoglobinuria | 2 |
61. Autoimmune hemolytic anemia
Clinical trials : 183 / Drugs : 119 - (DrugBank : 42) / Drug target genes : 31 - Drug target pathways : 156
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|
62. Paroxysmal nocturnal hemoglobinuria
Clinical trials : 358 / Drugs : 160 - (DrugBank : 35) / Drug target genes : 33 - Drug target pathways : 116
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|